Lacktman Quoted on Personalized Medicine in Florida
January 28, 2011
Tampa Bay Business Journal
Foley Senior Counsel Nathaniel Lacktman was quoted in an article that appeared in the Tampa Bay Business Journal on January 28, 2011 titled “Clinical trials seen as driving economic sector; M2Gen’s presence helping.” Lacktman discusses the efforts of M2Gen, the for-profit subsidiary of Moffitt Cancer Center, to help position the Tampa Bay region as a national leader in drug development. He states that M2Gen’s work should draw drug developers, physicians and other service providers to the area.
People
Related News
March 4, 2026
In the News
Christopher Ward Analyzes Uncertain Future of State Captive‑Audience Laws
Foley & Lardner LLP partner Christopher Ward was quoted in the Law360 article, “State Captive Audience Bans Live On Despite Uncertainty,” analyzing the legal status and future prospects for state laws restricting captive audience meetings.
March 3, 2026
In the News
Patrick Daugherty Assesses Growing Popularity of Crypto ATMs
Foley & Lardner LLP partner Patrick Daugherty assessed the growing popularity of crypto ATMs in the C-Store Dive article, “Navigating the pros and cons of crypto ATMs for convenience retailers.”
March 3, 2026
In the News
Judith Waltz Weighs CMS Anti‑Fraud Tools, Provider Screening, and Moratorium Risks
Foley & Lardner LLP partner Judith Waltz was quoted in the Report on Medicare Compliance article, “Attestation May Send Some PBDs Packing; 'They May Find Things Have Eroded Over Time'” discussing the evolving anti-fraud ecosystem, the Centers for Medicare & Medicaid Services' (CMS) forthcoming provider screening tool, and benefits of moratorium.